BMC Gastroenterology · Published 2026-07-25 · DOI 10.1186/s12876-026-04804-7
Jeanne Jiang, Abigail Wojtowicz, Jennifer Uyei, He Jin, Kristina Lindsley, Marie Sanchirico
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Jiang, J., Wojtowicz, A., Uyei, J., et al. (2026). Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update. BMC Gastroenterology. https://doi.org/10.1186/s12876-026-04804-7